Skip to main content
. 2021 Jan 27;12(2):176. doi: 10.3390/genes12020176

Table 1.

Patient characteristics.

Factors n = 79
Age 63
Median, range (37–86)
Age
<65 45 (57)
≥65 34 (43)
Gender
Male 47 (59.5)
Female 32 (40.5)
Tumor location
Colon cancer 76 (96.2)
Rectal cancer 3 (3.8)
Pathologic T stage
Tis 1 (1.3)
T1 6 (7.6)
T2 3 (3.8)
T3 53 (67.1)
T4 16 (20.3)
Pathologic N stage
N0 38 (48.1)
N1 20 (25.3)
N2 21 (26.6)
Pathologic Stage
I 9 (4.5)
II 28 (35.4)
III 39 (49.4)
IV 3 (3.8)
Differentiation
well 3 (3.8)
moderate 53 (67.1)
poor 18 (22.8)
others 3 (3.8)
KRAS
wild 42 (53.2)
mutant 30 (38)
MSI
low 69 (87.3)
high 6 (7.6)
Histology
adenocarcinoma 78 (98.7)
others 1 (1.3)
Lymphovascular invasion
present 43 (54.4)
absent 35 (44.3)
Venous invasion
present 43 (54.4)
absent 32 (40.5)
Perineural invasion
present 54 (68.4)
absent 24 (30.4)
lymphocyte response
present 57 (72.2)
absent 18 (22.8)
Recurrence 16 (20.3)
Death 4 (5.1)